Cargando…
Safety and Efficacy of the VariLift-C® Cervical Standalone Interbody Fusion Device with Emphasis on Multiple-level and Prior Fusion Cases
Introduction The VariLift-C(®) is a stand-alone, expandable, cervical interbody fusion device, not requiring the addition of anterior plating. Because of the access and placement technique, as well as not needing a plate, the device could potentially be used preferentially for patients with prior an...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837266/ https://www.ncbi.nlm.nih.gov/pubmed/31772855 http://dx.doi.org/10.7759/cureus.5885 |
_version_ | 1783467057985093632 |
---|---|
author | Maragkos, Georgios A Motiei-Langroudi, Rouzbeh Arle, Jeffrey |
author_facet | Maragkos, Georgios A Motiei-Langroudi, Rouzbeh Arle, Jeffrey |
author_sort | Maragkos, Georgios A |
collection | PubMed |
description | Introduction The VariLift-C(®) is a stand-alone, expandable, cervical interbody fusion device, not requiring the addition of anterior plating. Because of the access and placement technique, as well as not needing a plate, the device could potentially be used preferentially for patients with prior anterior fusions or for multiple, non-contiguous vertebral segments. Methods A retrospective chart review was conducted and all cases of anterior cervical discectomy and fusion (ACDF) using VariLift-C(®) implants by a single surgeon were included. Patient baseline and operative characteristics were collected, and their follow-up notes were searched for outcomes. Descriptive statistics are provided. Results Seventy-one patients were included in this study, 14 of which had had a prior fusion, and 32 underwent a multilevel ACDF. A total of 108 cervical levels were fused. Mean age (± SD) at surgery was 50.3 ± 11.4 years and mean (± SD) follow-up was 6.5 ± 10.7 months. There were 39 single-level, 27 two-level and five three-level fusions. Four cases (5.6%) underwent multilevel re-operations. Thirty-three patients (80.3%) reported substantial improvement in their symptoms on follow-up, 19 of whom (26.8%) had no residual symptoms. Only two patients (2.8%) reported a worsened condition after surgery. There were 10 cases (12.8%) of postoperative neurologic deficit, one case of dysphagia and three cases of vocal cord paresis. Conclusions These results display the use of VariLift-C(®) for symptomatic cervical degenerative disorders, with a focus on fusion extension or multiple-segment ACDF procedures. Our experience with favorable self-reported outcomes and low complication rates showcases the safety and efficacy of the VariLift-C(®) device for ACDF. |
format | Online Article Text |
id | pubmed-6837266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-68372662019-11-26 Safety and Efficacy of the VariLift-C® Cervical Standalone Interbody Fusion Device with Emphasis on Multiple-level and Prior Fusion Cases Maragkos, Georgios A Motiei-Langroudi, Rouzbeh Arle, Jeffrey Cureus Neurosurgery Introduction The VariLift-C(®) is a stand-alone, expandable, cervical interbody fusion device, not requiring the addition of anterior plating. Because of the access and placement technique, as well as not needing a plate, the device could potentially be used preferentially for patients with prior anterior fusions or for multiple, non-contiguous vertebral segments. Methods A retrospective chart review was conducted and all cases of anterior cervical discectomy and fusion (ACDF) using VariLift-C(®) implants by a single surgeon were included. Patient baseline and operative characteristics were collected, and their follow-up notes were searched for outcomes. Descriptive statistics are provided. Results Seventy-one patients were included in this study, 14 of which had had a prior fusion, and 32 underwent a multilevel ACDF. A total of 108 cervical levels were fused. Mean age (± SD) at surgery was 50.3 ± 11.4 years and mean (± SD) follow-up was 6.5 ± 10.7 months. There were 39 single-level, 27 two-level and five three-level fusions. Four cases (5.6%) underwent multilevel re-operations. Thirty-three patients (80.3%) reported substantial improvement in their symptoms on follow-up, 19 of whom (26.8%) had no residual symptoms. Only two patients (2.8%) reported a worsened condition after surgery. There were 10 cases (12.8%) of postoperative neurologic deficit, one case of dysphagia and three cases of vocal cord paresis. Conclusions These results display the use of VariLift-C(®) for symptomatic cervical degenerative disorders, with a focus on fusion extension or multiple-segment ACDF procedures. Our experience with favorable self-reported outcomes and low complication rates showcases the safety and efficacy of the VariLift-C(®) device for ACDF. Cureus 2019-10-10 /pmc/articles/PMC6837266/ /pubmed/31772855 http://dx.doi.org/10.7759/cureus.5885 Text en Copyright © 2019, Maragkos et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Neurosurgery Maragkos, Georgios A Motiei-Langroudi, Rouzbeh Arle, Jeffrey Safety and Efficacy of the VariLift-C® Cervical Standalone Interbody Fusion Device with Emphasis on Multiple-level and Prior Fusion Cases |
title | Safety and Efficacy of the VariLift-C® Cervical Standalone Interbody Fusion Device with Emphasis on Multiple-level and Prior Fusion Cases |
title_full | Safety and Efficacy of the VariLift-C® Cervical Standalone Interbody Fusion Device with Emphasis on Multiple-level and Prior Fusion Cases |
title_fullStr | Safety and Efficacy of the VariLift-C® Cervical Standalone Interbody Fusion Device with Emphasis on Multiple-level and Prior Fusion Cases |
title_full_unstemmed | Safety and Efficacy of the VariLift-C® Cervical Standalone Interbody Fusion Device with Emphasis on Multiple-level and Prior Fusion Cases |
title_short | Safety and Efficacy of the VariLift-C® Cervical Standalone Interbody Fusion Device with Emphasis on Multiple-level and Prior Fusion Cases |
title_sort | safety and efficacy of the varilift-c® cervical standalone interbody fusion device with emphasis on multiple-level and prior fusion cases |
topic | Neurosurgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837266/ https://www.ncbi.nlm.nih.gov/pubmed/31772855 http://dx.doi.org/10.7759/cureus.5885 |
work_keys_str_mv | AT maragkosgeorgiosa safetyandefficacyofthevariliftccervicalstandaloneinterbodyfusiondevicewithemphasisonmultiplelevelandpriorfusioncases AT motieilangroudirouzbeh safetyandefficacyofthevariliftccervicalstandaloneinterbodyfusiondevicewithemphasisonmultiplelevelandpriorfusioncases AT arlejeffrey safetyandefficacyofthevariliftccervicalstandaloneinterbodyfusiondevicewithemphasisonmultiplelevelandpriorfusioncases |